Contains fulltext : 164517.pdf (publisher's version ) (Closed access)OBJECTIVE: To estimate BRCA1/2 mutation carriers' cumulative ovarian cancer risks after risk-reducing salpingectomy at various ages with delayed oophorectomy several years later compared with risk-reducing salpingo-oophorectomy. METHODS: A literature search was performed on cumulative ovarian cancer risks and effects of risk-reducing salpingo-oophorectomy and salpingectomy. Results were used in a modeling study to estimate cumulative ovarian cancer risks for various scenarios of salpingectomy with delayed oophorectomy and risk-reducing salpingo-oophorectomy using Cox proportional hazard models. RESULTS: Estimated cumulative ovarian cancer risks at age 70 ...
OBJECTIVE: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
PURPOSE: Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidat...
Item does not contain fulltextBACKGROUND: Previous studies have reported a breast cancer (BC) risk r...
Contains fulltext : 171930.pdf (publisher's version ) (Closed access)OBJECTIVE: Ri...
Item does not contain fulltextIMPORTANCE: Most women with a BRCA1/2 pathogenic variant undergo prema...
Contains fulltext : 155103.pdf (publisher's version ) (Open Access)BACKGROUND: Ris...
Item does not contain fulltextPURPOSE: Women with BRCA1/2 gene mutations who have completed their ch...
OBJECTIVE: Risk-reducing salpingo-oophorectomy (RRSO) is the only effective surgical strategy to red...
Objective: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
Objective: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
Objective: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
OBJECTIVE: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
PURPOSE: Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidat...
Item does not contain fulltextBACKGROUND: Previous studies have reported a breast cancer (BC) risk r...
Contains fulltext : 171930.pdf (publisher's version ) (Closed access)OBJECTIVE: Ri...
Item does not contain fulltextIMPORTANCE: Most women with a BRCA1/2 pathogenic variant undergo prema...
Contains fulltext : 155103.pdf (publisher's version ) (Open Access)BACKGROUND: Ris...
Item does not contain fulltextPURPOSE: Women with BRCA1/2 gene mutations who have completed their ch...
OBJECTIVE: Risk-reducing salpingo-oophorectomy (RRSO) is the only effective surgical strategy to red...
Objective: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
Objective: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
Objective: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
Objective: Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family ca...
OBJECTIVE: Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HB...
PURPOSE: Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidat...
Item does not contain fulltextBACKGROUND: Previous studies have reported a breast cancer (BC) risk r...